Peptide nucleic acids (PNAs) are synthetic analogues of DNA in which the sugar–phosphate backbone is replaced by a neutral peptide-like scaffold. This modification endows PNAs with exceptional ...

This study introduces a novel signal amplification method induced by aggregation, which achieves specific recognition and sensitive detection of two cancer biomarkers through the rational design of ...

Marina Biotech, Inc. a leading RNAi-based drug discovery and development company, announced that the Japanese Patent Office has issued patent application 2007-509522 covering its proprietary nucleic ...

The expanding field of short peptide bioregulators has generated sustained interest in recent decades, particularly in ...

Yet it is just one in a rapidly growing class of drugs called peptide therapeutics that sits between small molecules (like aspirin) and biologics (like antibodies). A UC Santa Barbara research team ...

Merck researchers developed a highly sustainable way to synthesize the macrocyclic peptide drug enlicitide, increasing ...

Led by Associate Professor Hiroya Kuwahara of Department of Neurology and Neurological Science and the Nucleotide and Peptide ...